NCT00576329View on ClinicalTrials.gov

Topical 0.4% Ketorolac and Vitreoretinal Surgery

PHASE2/PHASE3CompletedINTERVENTIONAL

Enrollment

76

Participants

Timeline

Start Date

November 30, 2006

Study Completion Date

October 31, 2007

Conditions

Surgery

Interventions

DRUG

Ketorolac

Topical use before surgery

Trial Locations (1)

30322

Emory Eye Clinic, Atlanta

All Listed Sponsors

lead

Emory University

OTHER

NCT00576329 - Topical 0.4% Ketorolac and Vitreoretinal Surgery | Biotech Hunter | Biotech Hunter